Annual Current Liabilities
$15.68 M
+$9.56 M+156.11%
December 31, 2021
Summary
- As of February 8, 2025, ALNA annual total current liabilities is $15.68 million, with the most recent change of +$9.56 million (+156.11%) on December 31, 2021.
- During the last 3 years, ALNA annual current liabilities has risen by +$9.92 million (+172.06%).
Performance
ALNA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$10.43 M
+$309.00 K+3.05%
June 30, 2022
Summary
- As of February 8, 2025, ALNA quarterly total current liabilities is $10.43 million, with the most recent change of +$309.00 thousand (+3.05%) on June 30, 2022.
- Over the past year, ALNA quarterly current liabilities has increased by +$2.63 million (+33.71%).
Performance
ALNA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ALNA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +156.1% | +33.7% |
| 3 y3 years | +172.1% | +35.7% |
| 5 y5 years | +107.9% | +150.0% |
ALNA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -33.5% | -3.0% |
| 5 y | 5-year | at high | -61.0% | -33.5% | -62.4% |
| alltime | all time | at high | -79.3% | -33.5% | -73.9% |
Allena Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $10.43 M(+3.1%) |
| Mar 2022 | - | $10.12 M(-35.5%) |
| Dec 2021 | $15.68 M(+156.1%) | $15.68 M(+104.3%) |
| Sep 2021 | - | $7.67 M(-1.6%) |
| Jun 2021 | - | $7.80 M(+15.5%) |
| Mar 2021 | - | $6.75 M(+10.2%) |
| Dec 2020 | $6.12 M(-43.9%) | $6.12 M(+56.3%) |
| Sep 2020 | - | $3.92 M(-41.9%) |
| Jun 2020 | - | $6.74 M(-16.0%) |
| Mar 2020 | - | $8.02 M(-26.4%) |
| Dec 2019 | $10.91 M | $10.91 M(+4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $10.49 M(+36.5%) |
| Jun 2019 | - | $7.68 M(+13.4%) |
| Mar 2019 | - | $6.78 M(+17.6%) |
| Dec 2018 | $5.76 M(-23.6%) | $5.76 M(+16.7%) |
| Sep 2018 | - | $4.94 M(+81.2%) |
| Jun 2018 | - | $2.73 M(-62.4%) |
| Mar 2018 | - | $7.25 M(-3.9%) |
| Dec 2017 | $7.54 M(+132.1%) | $7.54 M(+5.7%) |
| Sep 2017 | - | $7.14 M(+71.2%) |
| Jun 2017 | - | $4.17 M(+28.3%) |
| Dec 2016 | $3.25 M(-36.8%) | $3.25 M |
| Dec 2015 | $5.14 M | - |
FAQ
- What is Allena Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Allena Pharmaceuticals?
- What is Allena Pharmaceuticals annual current liabilities year-on-year change?
- What is Allena Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Allena Pharmaceuticals?
- What is Allena Pharmaceuticals quarterly current liabilities year-on-year change?
What is Allena Pharmaceuticals annual total current liabilities?
The current annual current liabilities of ALNA is $15.68 M
What is the all time high annual current liabilities for Allena Pharmaceuticals?
Allena Pharmaceuticals all-time high annual total current liabilities is $15.68 M
What is Allena Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, ALNA annual total current liabilities has changed by +$9.56 M (+156.11%)
What is Allena Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of ALNA is $10.43 M
What is the all time high quarterly current liabilities for Allena Pharmaceuticals?
Allena Pharmaceuticals all-time high quarterly total current liabilities is $15.68 M
What is Allena Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, ALNA quarterly total current liabilities has changed by +$2.63 M (+33.71%)